JESSICA LAFOLLETTE: Open Payments
NPI 1740892165 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,072 in 47 payments from 17 companies in 2025. Trend: 2023 $1,012 · 2024 $965 · 2025 $1,072
Food & beverage: $1,072
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 10 | $218 |
| Ardelyx, Inc. | 7 | $180 |
| Fresenius USA Marketing, Inc. | 4 | $91 |
| AstraZeneca Pharmaceuticals LP | 5 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $64 |
| Travere Therapeutics, Inc. | 2 | $56 |
| Aurinia Pharma U.S., Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Vifor Pharma, Inc. | 2 | $50 |
| Vantive US Healthcare LLC | 1 | $40 |
Products named: IBSRELA, KRYSTEXXA, VELPHORO, FARXIGA, Kerendia, LUPKYNIS, JYNARQUE, Veltassa.
Industry payments across KY — which companies pay providers there.
